Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.48 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.47 |
| ▸ | TUBB | P07437 | 1/20 | 0.47 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.47 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.47 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.47 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.47 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.47 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.47 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.47 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.47 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.47 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.47 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9918736 | 0.85 | ALDH1A1 (0.50) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL23245989 | 0.85 | FBP1 (0.56) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL589219 | 0.83 | ALDH1A1 (0.61) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL4513102 | 0.83 | ALDH1A1 (0.75) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL1504624 | 0.83 | PKM (0.60) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL13485768 | 0.82 | ALDH1A1 (0.54) | FBP1ALDH1A1PKMCA1CA2 | |
| Hydrochloric Acid SCHEMBL1891433 | 0.82 | PKM (0.59) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL1370629 | 0.82 | ALDH1A1 (0.56) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL1370626 | 0.82 | ALDH1A1 (0.56) | FBP1ALDH1A1PKMCA1CA2 | |
| SCHEMBL21807392 | 0.80 | FBP1 (0.53) | FBP1ALDH1A1CA1CA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024064745-A1 | SYNTHESIS OF RELDESEMTIV | CYTOKINETICS, INCORPORATED (US) | 2024-03-28 | — | — | WO | claimed |
| WO-2024064745-A1 | SYNTHESIS OF RELDESEMTIV | CYTOKINETICS, INCORPORATED (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024064745-A1 | SYNTHESIS OF RELDESEMTIV | CYTOKINETICS, INCORPORATED (US) | 2024-03-28 | — | — | WO | disclosed |
| US-20210347780-A1 | CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO | Vyera Pharmaceuticals, LLC | 2021-11-11 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| WO-2007018439-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007018439-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347780-A1 | CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO | CAMKK1, CAMK1, CAMKK2 | FBP1 1013/4885ALDH1A1 4701/4885PKM 1001/4885 |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | PIN1, PPIA, PARG | FBP1 3450/4885ALDH1A1 3846/4885PKM 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.